Phase 3 trials of CagriSema demonstrated: 15.6% body weight loss with the combination versus 8.1% with semaglutide alone Superior glycemic control compared to either component individually Manageable side effect profile with proper dose titration Regulatory submissions completed in 2024 for obesity treatment [6] Since retatrutide includes GLP-1 receptor activation (similar to semaglutide) plus additional GIP and glucagon receptor effects, the theoretical cagrilintide blend with retatrutide could potentially exceed even the impressive CagriSema results
Now that you know R-lipoic acid is more effective than ALA, its important to take it under your doctor's supervision
Increased motor cortex white matter volume predicts motor impairment in autism
Dubchenko E, Ivanov A, Spirina N, Smirnova N, Melnikov M, Boyko A, Gusev E, Kubatiev A (2020) Hyperhomocysteinemia and endothelial dysfunction in multiple sclerosis
It is often used for chronic neck pain, facet joint irritation, and soft tissue injuries
For the players who built their infrastructure around GLP-1s, this is the place to go, says Wheels Davey